Antisense makes sense for Doreen

I DON'T know how she does it. Oh, wait, yes I do. Doreen Daze has peered past the veil which cloaks tomorrow from today to once again drink deep from the brimming goblet of shares race glory. Professional investors are always banging on about what sets them apart from the crowd how about "can see into the future" as a competitive advantage?

By InvestSMART · 20 Nov 2011

By InvestSMART ·
20 Nov 2011

Comments

From an uncharacteristically sensible portfolio, the one speccy stock in there - Antisense Therapeutics (a name likely to give even the most hardened investor pause, although quite apt in the case of Doreen) - has added more than $10,000 to Ms Daze's pile. There wasn't any sense in the share price spike, either: the company told the ASX it didn't know why its shares jumped so sharply.

Anyway, that was enough to pip a chartist who was desperate for a return to winning ways. Richard Pritchard led from the start but couldn't match the late dash from Doreen. Heartbroken, Richard returns to his cave for a much-needed piece of Excel therapy.

Reader Gary Scott was the best of the rest and claims a credible third spot. He made 6.1 per cent on his money overall, better than the top 200's 3.5 per cent. His picks of Fortescue, Iluka and Rio did well in a race where resource stocks outperformed.

Despite a weak final week, Pottsy finishes in the top half of the table, beating off a late surge from nurse Denise Borthwick, who, aside from Doreen, was the standout performer during the final leg thanks to Lynas Corp.

Retired valuer Jim Gracie only slightly underperformed the market, while year 7 student Rafael Ungar's stocks showed decidedly mixed returns, which is the story of the market, really. Next week: a new race!

Patrick Commins

Go to Google News, then click "Follow" button to add us.

Share this article and show your support

Frequently Asked Questions about this Article…

What caused the Antisense Therapeutics share price spike mentioned in the article?

The article says Antisense Therapeutics' shares jumped sharply but the company told the ASX it didn't know why the spike occurred—no clear explanation was provided.

How much did Antisense Therapeutics add to Doreen Daze's portfolio?

According to the article, the one speculative stock in Doreen Daze's portfolio, Antisense Therapeutics, added more than $10,000 to her holdings during the share price move.

Is Antisense Therapeutics described as a speculative stock in the piece?

Yes. The article explicitly refers to Antisense Therapeutics as the 'one speccy stock' in Doreen's otherwise sensible portfolio, noting its speculative nature and even that the company's name might give some investors pause.

Which resource stocks did well in the race covered by the article?

The article highlights that resource stocks outperformed overall. It specifically mentions Fortescue, Iluka and Rio as strong performers for reader Gary Scott, and Lynas Corp as a standout for Denise Borthwick late in the race.

Who were the top individual performers in the race and how did they fare?

Doreen Daze won the race thanks in part to the Antisense surge. Richard Pritchard led early but was overtaken, Gary Scott finished a credible third, Pottsy ended in the top half, Denise Borthwick had a late surge, Jim Gracie slightly underperformed the market, and student Rafael Ungar posted mixed results.

What return did reader Gary Scott achieve compared with the top 200 benchmark mentioned?

Gary Scott made 6.1% on his portfolio overall, which the article notes was better than the top 200's return of 3.5% during the same period.

Did Antisense Therapeutics tell the ASX why its shares jumped?

No. The article reports that Antisense told the ASX it did not know why its shares had jumped so sharply, leaving the move unexplained publicly.

What small practical lessons for everyday investors does the article illustrate about unexplained share spikes and speculative picks?

The article illustrates that unexplained share spikes can produce swift, large gains for speculative holdings—Doreen's Antisense position added over $10,000—but that these events can be unpredictable and drivers may remain unclear. It also shows resource stocks can outperform in certain periods, influencing contest outcomes.